S-EPMC12804822 - Establishing FDA-approved oncology drugs as GPR176 inhibitor through homology modelling, molecular docking, MMGBSA, DFT, and molecular dynamics simulation. - OmicsDI

Unknown

Dataset Information

Establishing FDA-approved oncology drugs as GPR176 inhibitor through homology modelling, molecular docking, MMGBSA, DFT, and molecular dynamics simulation.

ABSTRACT:

SUBMITTER: Ishabiyi FO

PROVIDER: S-EPMC12804822 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature